CCMLC
BIO icon

Cardinal Capital Management LLC (Connecticut)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cardinal Capital Management LLC (Connecticut)’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-7,000
Closed -$865K – 107
2013
Q4 		$865K Sell
7,000
-43,216
-86% -$5.27M 0.05% 103
2013
Q3 		$5.9M Buy
+50,216
New +$5.92M 0.36% 63

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cardinal Capital Management LLC (Connecticut)'s BIO Position: Q1 2014 in Review

Cardinal Capital Management LLC (Connecticut) sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2014, closing a stake of 7,000 shares — an estimated $865K sold.

Cardinal Capital Management LLC (Connecticut) first reported a position in BIO in Q3 2013 and held it in 2 quarters. The position peaked at $5.9M in Q3 2013. 193 funds tracked by Wall St. Rank hold BIO as of Q1 2014.

  • Cardinal Capital Management LLC (Connecticut) reported no remaining Bio-Rad Laboratories Class A position as of Q1 2014 after selling out during the quarter.
  • Cardinal Capital Management LLC (Connecticut) sold 7,000 Bio-Rad Laboratories Class A shares in Q1 2014, an estimated $865K.
  • Cardinal Capital Management LLC (Connecticut) first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and held it in 2 quarters.
  • Cardinal Capital Management LLC (Connecticut)'s Bio-Rad Laboratories Class A position peaked at $5.9M in Q3 2013.
  • 193 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2014.

Based on Cardinal Capital Management LLC (Connecticut)'s 13F filing for Q1 2014, filed 15 May 2014.